Study of Evaluation of Cavir Tab. 0.5mg With Food Effect on Pharmacokinetics and Safety
Status:
Unknown status
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
In this clinical trial, the investigator will clarify the difference in pharmacokinetics
between the group single dose Cavir Tab. 0.5mg and single dose Cavir Tab. 0.5mg with high
fatty meal for healthy adult volunteer.
The investigators evaluate the effect of food intake on the absorption of Cavir Tab. 0.5mg.